Pre-eclampsia: does cardiac function differ in HIV-positive and -negative women?

Area of Science:

• Cardiology
• Infectious Diseases
• Obstetrics

Background:

• Cardiovascular diseases complicate pregnancies affected by HIV and pre-eclampsia.
• Pre-eclampsia is linked to both systolic and diastolic cardiac dysfunction.
• A dual, bidirectional pathophysiology may link placental factors, cardiac function, and pre-eclampsia risk.

Purpose of the Study:

• To establish the impact of pre-eclampsia and HIV infection on cardiac function.
• To explore the interrelated pathophysiology of cardiovascular disease, HIV, and pre-eclampsia.
• To identify areas for future research and therapeutic interventions.

Main Methods:

• Literature review synthesizing existing research on pre-eclampsia, HIV, and cardiac function.
• Analysis of pathophysiological links between cardiovascular disease, HIV, and pre-eclampsia.
• Identification of the influence of antiretroviral therapy on cardiac function.

Main Results:

• Both pre-eclampsia and HIV infection contribute to cardiac dysfunction.
• Antiretroviral therapy also impacts cardiac function.
• The interplay between these conditions presents significant cardiovascular challenges.

Conclusions:

• Pre-eclampsia and HIV infection significantly affect cardiac function.
• Understanding the bidirectional pathophysiology is key for future interventions.
• Further research is needed to develop novel therapeutic strategies for these complex conditions.